Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
5
×
boston blog main
boston top stories
clinical trials
san francisco blog main
biotech
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
boston
eli lilly
fda
indiana blog main
indiana top stories
pfizer
rna interference
wisconsin blog main
wisconsin top stories
abbvie
acorda therapeutics
acute myeloid leukemia
adverum biotechnologies
akcea therapeutics
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceutials
alnylam pharmaceuticals
ambit biosciences
amgen
ampyra
andrew fire
apokyn
apomorphine
arrowhead pharmaceuticals
athena countouriotis
boehringer ingelheim
What
gets
5
×
drug
fda
new
approved
medicines
nod
rnai
abandoning
acorda
afternoon
ago
alnylam
alnylam’s
amgen
approval
athena
baggage
biotech
cancer
candidates
ceo
chief
class
companies
cope
countouriotis
cuts
deal
developed
development
dicerna
disease
episodes
financing
free
friday
head
help
history
Language
Current search:
gets
×
" national top stories "
×
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines